2021
DOI: 10.3390/pathogens10050577
|View full text |Cite
|
Sign up to set email alerts
|

Oropharyngeal Carriage of hpl-Containing Haemophilus haemolyticus Predicts Lower Prevalence and Density of NTHi Colonisation in Healthy Adults

Abstract: Nontypeable Haemophilus influenzae (NTHi) is a major respiratory pathogen that initiates infection by colonising the upper airways. Strategies that interfere with this interaction may therefore have a clinically significant impact on the ability of NTHi to cause disease. We have previously shown that strains of the commensal bacterium Haemophilus haemolyticus (Hh) that produce a novel haem-binding protein, haemophilin, can prevent NTHi growth and interactions with host cells in vitro. We hypothesized that natu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…Likewise, intranasal administration of Bifidobacterium longum reduced influenza viral load in a mouse model [ 222 ]. Other studies show oropharyngeal H. haemolyticus carriage correlates with reduced NTHi prevalence and density [ 223 ], with anti-NTHi activity also demonstrated in vitro [ 83 ]. Taken together, these data indicate potential therapeutic utility of respiratory-administered probiotics; however, progression of respiratory probiotics into clinical trials first requires improved understanding of the key microbes and metabolites, delivery methods, timing, efficacy in humans, effect duration, safety, and generalisability of use (for example, among children or those with existing chronic lung disease).…”
Section: Emerging Therapeutic Approachesmentioning
confidence: 99%
“…Likewise, intranasal administration of Bifidobacterium longum reduced influenza viral load in a mouse model [ 222 ]. Other studies show oropharyngeal H. haemolyticus carriage correlates with reduced NTHi prevalence and density [ 223 ], with anti-NTHi activity also demonstrated in vitro [ 83 ]. Taken together, these data indicate potential therapeutic utility of respiratory-administered probiotics; however, progression of respiratory probiotics into clinical trials first requires improved understanding of the key microbes and metabolites, delivery methods, timing, efficacy in humans, effect duration, safety, and generalisability of use (for example, among children or those with existing chronic lung disease).…”
Section: Emerging Therapeutic Approachesmentioning
confidence: 99%
“…Importantly, Hpl binds heme in a manner that cannot be utilized by NTHi, thus inhibiting NTHi growth in vitro ( 17 20 ). In humans, colonization with Hpl-expressing H. haemolyticus is associated with lower NTHi burdens in the upper airway and a reduced risk of NTHi acquisition, suggesting a beneficial role for Hpl expression ( 21 ). Here, we investigated the hypothesis that H. haemolyticus reduces NTHi burdens in the upper and lower airway in an Hpl-dependent manner and determined whether recombinant Hpl was sufficient for protection against NTHi colonization and lung infection.…”
Section: Introductionmentioning
confidence: 99%
“…Hemophilin producing strains of H. haemolyticus inhibit the growth of H. influenzae significantly more than non-hemophilin encoding strains in co-cultured media [18] and cell cultures [20]. Additionally, oropharyngeal sampling of human subjects indicates that individuals who carry hemophilin encoding H. haemolyticus are between 2.43 and 2.67 times less likely to carry nontypeable H. influenzae [21]. Conversely, within the opportunistic pathogen A. baumannii, hemophilin can act as a virulence factor by facilitating systemic infection in a murine model [13].…”
Section: Introductionmentioning
confidence: 99%